Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Martin Paul Kaminski, M.D.

Concepts (21)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Patients220239061.070 Why?
Teaching Rounds120232750.620 Why?
Health Care Costs1202332570.340 Why?
Blood Coagulation Tests120232700.200 Why?
Cost-Benefit Analysis1202355080.090 Why?
Antitubercular Agents1200913740.050 Why?
Patient Compliance1200926890.040 Why?
Tuberculosis1200920030.030 Why?
Humans320237602760.020 Why?
Isoniazid120092830.020 Why?
Rifampin120093410.020 Why?
Massachusetts1200988050.010 Why?
Liver1200975100.010 Why?
Aged, 80 and over12009589530.000 Why?
Young Adult12009586730.000 Why?
Treatment Outcome12009649680.000 Why?
Aged120091690020.000 Why?
Middle Aged120092201790.000 Why?
Adult120092198430.000 Why?
Male120093594270.000 Why?
Female120093910240.000 Why?
Kaminski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (21)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.